Lnc-CCNH-8 promotes immune escape by up-regulating PD-L1 in hepatocellular carcinoma

• Main Authors: Bixing Zhao (Author), Xiaoyuan Zheng (Author), Yang Wang (Author), Niangmei Cheng (Author), Yue Zhong (Author), Yang Zhou (Author), Jingyun Huang (Author), Fei Wang (Author), Xin Qi (Author), Qiuyu Zhuang (Author), Yingchao Wang (Author), Xiaolong Liu (Author)
• Format: Book
• Published: Elsevier, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hepatocellular carcinoma (HCC) is a common malignancy with poor prognosis. In recent years, immune checkpoint inhibitors (ICIs) have enabled breakthroughs in the clinical treatment of patients with HCC, but the overall response rate to ICIs in HCC patients is still low, and no validated biomarker is...